1-4 of 4
Katharina Kleinschmidt
Close
Sort by
Journal Articles

Haploidentical Aß T Cell Depleted HSCT Represents an Alternative Treatment Option in Pediatric and Adult Patients with Sickle Cell Disease (SCD)

Selim Corbacioglu, Anja Troeger, Katharina Kleinschmidt, Tarek Hanafee-Alali, Andreas-Michael Brosig, Marcus Jakob, Sonja Kramer, Robert Offner, Daniel Wolff, Juergen Foell
Journal: Blood
Blood (2023) 142 (Supplement 1): 4915.
https://doi.org/10.1182/blood-2023-189434
Published: 2023
Journal Articles

Treosulfan Based Haploidentical Αß T Cell Depleted HSCT Represents a Curative Alternative in Pediatric and Adult Patients with Transfusion Dependent Thalassaemia

Anja Troeger, Katharina Kleinschmidt, Tarek Hanafee-Alali, Andreas-Michael Brosig, Marcus Jakob, Sonja Kramer, Robert Offner, Daniel Wolff, Juergen Foell, Selim Corbacioglu
Journal: Blood
Blood (2023) 142 (Supplement 1): 2169.
https://doi.org/10.1182/blood-2023-189695
Published: 2023
Journal Articles

Feasibility of Peripheral Blood Stem Cell Collection from Heterozygoussickle Cell Trait Donors

Juergen Foell, MD, Morad Morez, Anja Troeger, MD, Katharina Kleinschmidt, MD PhD, Beatrix Pfirstinger, Andreas Brosig, MD PhD, Ralph Burkhardt, MD PhD, Selim Corbacioglu, MD, Norbert Ahrens
Journal: Blood
Blood (2019) 134 (Supplement_1): 1171.
https://doi.org/10.1182/blood-2019-131984
Published: 2019
Journal Articles

Assessment of Calcineurin Inhibitor-Associated Neurotoxicity in Patients with Sickle Cell Disease Receiving a Matched Sibling Donor or T-Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation

Katharina Kleinschmidt, MD PhD, Juergen Foell, MD, Johannes Schulte, Beatrix Pfirstinger, MD, Anja Troeger, MD, Charalampos Aslanidis, PhD, Daniel Wolff, MD, Matthias Edinger, MD PhD, Ernst Holler, MD, Wolfgang Herr, MD, Angelika Eggert, MD PhD, Selim Corbacioglu, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2088.
https://doi.org/10.1182/blood-2018-99-115988
Published: 2018